Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
The expected taxonomic range for this enzyme is: Arthrobacter sp. TS-15
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(-)-(1R,2S)-ephedrine + NAD+
(S)-2-methylamino-1-phenylpropan-1-one + NADH + H+
(4-chlorophenyl)-2-pyridinylmethanone + NAD+
(S)-(4-chlorophenyl)(pyridin-2-yl)methanol + NADH + H+
specifc activity: 1.74 U/mg. Product: 70% (S) enantiomeric excess
-
-
?
(4-chlorophenyl)-2-pyridinylmethanone + NADH + H+
(R)-(4-chlorophenyl)(pyridin-2-yl)methanol + NAD+
2.7% of the activity as compared to 1-phenyl-1,2-propanedione. The (R)-enantiomer is formed with 70% enantiomeric excess
-
-
?
(R,R)-(-)-pseudoephedrine + NAD+
? + NADH + H+
the enzyme exhibits a strict enantioselectivity for the oxidation of (-)-(1R,2S)-ephedrine and (R,R)-(-)-pseudoephedrine
-
-
?
1,2-indandione + NAD+
? + NADH + H+
specifc 50.05 U/mg
-
-
?
1,2-indanedione + NADH + H+
1-hydroxy-1,3-dihydro-2H-inden-2-one + NAD+
78.1% of the activity as compared to 1-phenyl-1,2-propanedione
-
-
?
1,2-naphthoquinone + NAD+
? + NADH + H+
specifc activity: 13.89 U/mg
-
-
?
1,2-naphthoquinone + NADH + H+
1-hydroxynaphthalen-2(1H)-one + NAD+
21.7% of the activity as compared to 1-phenyl-1,2-propanedione
-
-
?
1-phenyl-1,2-propanedione + NAD+
(R)-phenylacetylcarbinol + NADH + H+
specifc activity: 64.02 U/mg. Product: 99% (R) enantiomeric excess
-
-
?
1-phenyl-1,2-propanedione + NADH + H+
(R)-phenylacetylcarbinol + NAD+
substrate with highest activity. Full conversion and enantiomeric excess of more than 99%
-
-
?
1-phenyl-1,3-butanedione + NAD+
(4R)-4-hydroxy-4-phenylbutan-2-one + NADH + H+
specifc activity: 13.64 U/mg. Product: 98% (R) enantiomeric excess
-
-
?
1-phenyl-1,3-butanedione + NADH + H+
(4R)-4-hydroxy-4-phenylbutan-2-one + NAD+
21.3% of the activity as compared to 1-phenyl-1,2-propanedione. The (R)-enantiomer is formed with 98% enantiomeric excess
-
-
?
1-phenyl-1-propanone + NAD+
(1R)-1-phenylpropan-1-ol + NADH + H+
specifc activity: 1.55 U/mg. Product: 99% (R) enantiomeric excess
-
-
?
1-phenyl-1-propanone + NADH + H+
(1R)-1-phenylpropan-1-ol + NAD+
2.4% of the activity as compared to 1-phenyl-1,2-propanedione. The (R)-enantiomer is formed with 99% enantiomeric excess
-
-
?
2,2'-dichlorobenzil + NAD+
(2R)-1,2-bis(2-chlorophenyl)-2-hydroxyethan-1-one + NADH + H+
specifc activity: 27.91 U/mg. Product: 94% (R) enantiomeric excess
-
-
?
2,2'-dichlorobenzil + NADH + H+
(2R)-1,2-bis(2-chlorophenyl)-2-hydroxyethan-1-one + NAD+
43.6% of the activity as compared to 1-phenyl-1,2-propanedione. The (R)-enantiomer is formed with 4% enantiomeric excess
-
-
?
2,2'-furil + NAD+
(2R)-1,2-di(furan-2-yl)-2-hydroxyethan + NADH + H+
specifc activity: 19.95 U/mg. Product: 99% (R) enantiomeric excess
-
-
?
2,2'-furil + NADH + H+
(2R)-1,2-di(furan-2-yl)-2-hydroxyethan-1-one + NAD+
20% of the activity as compared to 1-phenyl-1,2-propanedione. The (R)-enantiomer is formed with 99% enantiomeric excess
-
-
?
2,2'-thenil + NAD+
(2R)-2-hydroxy-1,2-di(thiophen-2-yl)ethan-1-one + NADH + H+
specifc activity: 46.77 U/mg. Product: 99% (R) enantiomeric excess
-
-
?
2,2'-thenil + NADH + H+
(2R)-2-hydroxy-1,2-di(thiophen-2-yl)ethan-1-one + NAD+
46.8% of the activity as compared to 1-phenyl-1,2-propanedione. The (R)-enantiomer is formed with 99% enantiomeric excess
-
-
?
2-aminoacetophenone + NAD+
(1R)-2-amino-1-phenylethan-1-ol + NADH + H+
specifc activity: 25.79 U/mg. Product: 99% (R) enantiomeric excess
-
-
?
2-aminoacetophenone + NADH + H+
(1R)-2-amino-1-phenylethan-1-ol + NAD+
40.3% of the activity as compared to 1-phenyl-1,2-propanedione. The (R)-enantiomer is formed with 99% enantiomeric excess
-
-
?
2-bromo-1-(3-chlorophenyl)-1-propanone + NAD+
(R,S)-2-bromo-1-(3-chlorophenyl)propan-1-ol + NADH + H+
specifc activity: 5.1 U/mg
-
-
?
2-bromo-1-(3-chlorophenyl)-1-propanone + NADH + H+
2-bromo-1-(3-chlorophenyl)propan-1-ol + NAD+
7.9% of the activity as compared to 1-phenyl-1,2-propanedione
-
-
?
2-bromoacetophenone + NAD+
(1R)-2-bromo-1-phenylethan-1-ol + NADH + H+
specifc activity: 9.44 U/mg. Product: 85% (R) enantiomeric excess
-
-
?
2-bromoacetophenone + NADH + H+
(1R)-2-bromo-1-phenylethan-1-ol + NAD+
14.8% of the activity as compared to 1-phenyl-1,2-propanedione. The (R)-enantiomer is formed with 85% enantiomeric excess
-
-
?
2-chloro-1-phenyl-1-propane + NAD+
(R,S)-2-chloro-1-phenylpropan-1-ol + NADH + H+
specifc activity: 8.0 U/mg
-
-
?
2-chloro-1-phenyl-1-propanone + NADH + H+
2-chloro-1-phenyl-1-propan-1-ol + NAD+
12.5% of the activity as compared to 1-phenyl-1,2-propanedione
-
-
?
2-chloroacetophenone + NAD+
(1R)-2-chloro-1-phenylethan-1-ol + NADH + H+
specifc activity: 8.71 U/mg. Product: 98% (R) enantiomeric excess
-
-
?
2-chloroacetophenone + NADH + H+
(1R)-2-chloro-1-phenylethan-1-ol + NAD+
13.6% of the activity as compared to 1-phenyl-1,2-propanedione. The (R)-enantiomer is formed with 98% enantiomeric excess
-
-
?
2-thenoylacetonitrile + NAD+
(3R)-3-hydroxy-3-(thiophen-2-yl)propanenitril + NADH + H+
specifc activity: 6.87 U/mg. Product: 99% (R) enantiomeric excess
-
-
?
2-thenoylacetonitrile + NADH + H+
(2R)-hydroxy(thiophen-2-yl)acetonitrile + NAD+
6.87% of the activity as compared to 1-phenyl-1,2-propanedione. The (R)-enantiomer is formed with 99% enantiomeric excess
-
-
?
3-chloropropiophenone + NAD+
(1R)-3-chloro-1-phenylpropan-1-ol + NADH + H+
specifc activity: 4.45 U/mg. Product: 99% (R) enantiomeric excess
-
-
?
3-chloropropiophenone + NADH + H+
(1R)-3-chloro-1-phenylpropan-1-ol + NAD+
6.9% of the activity as compared to 1-phenyl-1,2-propanedione. The (R)-enantiomer is formed with 99% enantiomeric excess
-
-
?
4,4'-difluorobenzil + NAD+
(2R)-1,2-bis(4-fluorophenyl)-2-hydroxyethan-1-one + NADH + H+
specifc activity: 48.2 U/mg. Product: 99% (R) enantiomeric excess
-
-
?
4,4'-difluorobenzil + NADH + H+
(2R)-1,2-bis(4-fluorophenyl)-2-hydroxyethan-1-one + NAD+
75.3% of the activity as compared to 1-phenyl-1,2-propanedione. The (R)-enantiomer is formed with 99% enantiomeric excess
-
-
?
4,4'-dimethylbenzil + NAD+
(2R)-2-hydroxy-1,2-bis(4-methylphenyl)ethan-1-one + NADH + H+
specifc activity: 3.12 U/mg. Product: 99% (R) enantiomeric excess
-
-
?
4,4'-dimethylbenzil + NADH + H+
(2R)-1,2-bis(4-methylphenyl)-2-hydroxyethan-1-one + NAD+
4.8% of the activity as compared to 1-phenyl-1,2-propanedione. The (R)-enantiomer is formed with 99% enantiomeric excess
-
-
?
4-chlorobenzil + NAD+
? + NADH + H+
specifc activity: 6.5 U/mg. Product: 95% (R) enantiomeric excess
-
-
?
4-chlorobenzil + NADH + H+
? + NAD+
10.2% of the activity as compared to 1-phenyl-1,2-propanedione. The (R)-enantiomer is formed with 58% enantiomeric excess
-
-
?
benzil + NAD+
(2R)-2-hydroxy-1,2-diphenylethan-1-one + NADH + H+
specifc activity: 47.06 U/mg. Product: 99% enantiomeric (R) excess
-
-
?
benzil + NADH + H+
(2R)-2-hydroxy-1,2-diphenylethan-1-one + NAD+
73.5% of the activity as compared to 1-phenyl-1,2-propanedione. The (R)-enantiomer is formed with 99% enantiomeric excess
?
-
?
ethyl 2-chlorobenzoylacetate + NAD+
ethyl (R,S)-2-chloro-3-hydroxy-3-phenylpropanoate + NADH + H+
specifc activity: 35.21 U/mg
-
-
?
ethyl 2-chlorobenzoylacetate + NADH + H+
ethyl 2-chloro-3-hydroxy-3-phenylpropanoate + NAD+
54.9% of the activity as compared to 1-phenyl-1,2-propanedione
-
-
?
isatin + NAD+
? + NADH + H+
specifc activity: 7.84 U/mg. Product: 52% (R) enantiomeric excess
-
-
?
isatin + NADH + H+
(3R)-3-hydroxy-1,3-dihydro-2H-indol-2-one + NAD+
12.25% of the activity as compared to 1-phenyl-1,2-propanedione. The (R)-enantiomer is formed with 52% enantiomeric excess
-
-
?
methyl benzoylformate + NAD+
methyl (2R)-hydroxy(phenyl)acetate + NADH + H+
specifc activity: 46.56 U/mg. Product: 98% (R) enantiomeric excess
-
-
?
methyl benzoylformate + NADH + H+
methyl (2S)-hydroxy(phenyl)acetate + NAD+
72.7% of the activity as compared to 1-phenyl-1,2-propanedione. The (R)-enantiomer is formed with 98% enantiomeric excess
-
-
?
phenyl-2-pyridinylmethanone + NAD+
(R)-phenyl(pyridin-2-yl)methanol + NADH + H+
specifc activity: 2.81 U/mg. Product: 24% (R) enantiomeric excess
-
-
?
phenyl-2-pyridinylmethanone + NADH + H+
(R)-phenyl(pyridin-2-yl)methanol + NAD+
4.4% of the activity as compared to 1-phenyl-1,2-propanedione. The (R)-enantiomer is formed with 24% enantiomeric excess
-
-
?
phenylglyoxal + NAD+
(2R)-hydroxy(phenyl)acetaldehyde + NADH + H+
specifc activity: 12.1 U/mg. Product: 99% (R) enantiomeric excess
-
-
?
phenylglyoxal + NADH + H+
(2R)-hydroxy(phenyl)acetaldehyde + NAD+
18.9% of the activity as compared to 1-phenyl-1,2-propanedione. The (R)-enantiomer is formed with 99% enantiomeric excess
-
-
?
additional information
?
-
no activity on (S,N)-(+)-(pseudo)ephedrine or (R,N)-(-)-(pseudo)ephedrine
-
-
-
(-)-(1R,2S)-ephedrine + NAD+

(S)-2-methylamino-1-phenylpropan-1-one + NADH + H+
-
-
-
?
(-)-(1R,2S)-ephedrine + NAD+
(S)-2-methylamino-1-phenylpropan-1-one + NADH + H+
the enzyme acts on a broad range of different aryl-alkyl ketones, such as haloketones, ketoamines, diketones, and ketoesters. It accepts various types of aryl groups including phenyl-, pyridyl-, thienyl-, and furyl-rings, but the presence of an aromatic ring is essential for the activity. In addition, the presence of a functional group on the alkyl chain, such as an amine, a halogen, or a ketone, is also crucial. The enzyme exhibits a strict Prelog enantioselectivity. When acting on diketones, it catalyses the reduction of only the keto group closest to the ring, with no further reduction to the diol. (-)-(1R,2S)-ephedrine i.e. (1R,2S)-1-phenyl-1-hydroxy-2-methylaminopropane. (S)-2-methylamino-1-phenylpropan-1-one i.e. (S)-methcathinone
-
-
?
(-)-(1R,2S)-ephedrine + NAD+
(S)-2-methylamino-1-phenylpropan-1-one + NADH + H+
the enzyme exhibits a strict enantioselectivity for the oxidation of (-)-(1R,2S)-ephedrine and (R,R)-(-)-pseudoephedrine
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.